Search

Bahar Alawi Craigo

Examiner (ID: 2673, Phone: (571)270-1326 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1699, 1759, 1673, 1623, 4131
Total Applications
905
Issued Applications
360
Pending Applications
129
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10292238 [patent_doc_number] => 20150177238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS' [patent_app_type] => utility [patent_app_number] => 14/635164 [patent_app_country] => US [patent_app_date] => 2015-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7313 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635164 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/635164
PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS Mar 1, 2015 Abandoned
Array ( [id] => 10256370 [patent_doc_number] => 20150141367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'MODULATION OF GROWTH OF BIFIDOBACTERIA USING A COMBINATION OF OLIGOSACCHARIDES FOUND IN HUMAN MILK' [patent_app_type] => utility [patent_app_number] => 14/604951 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3178 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604951 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/604951
MODULATION OF GROWTH OF BIFIDOBACTERIA USING A COMBINATION OF OLIGOSACCHARIDES FOUND IN HUMAN MILK Jan 25, 2015
Array ( [id] => 10267133 [patent_doc_number] => 20150152130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'TRANS-RESVERATROL POLYSACCHARIDE, METHOD FOR PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/592702 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10561 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592702 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/592702
TRANS-RESVERATROL POLYSACCHARIDE, METHOD FOR PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME Jan 7, 2015 Abandoned
Array ( [id] => 16443704 [patent_doc_number] => 10835608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Polymer-carbohydrate conjugates for drug delivery technology [patent_app_type] => utility [patent_app_number] => 14/561219 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 19916 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561219 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/561219
Polymer-carbohydrate conjugates for drug delivery technology Dec 4, 2014 Issued
Array ( [id] => 9858442 [patent_doc_number] => 20150038458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/517792 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 16180 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517792 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/517792
Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof Oct 16, 2014 Abandoned
Array ( [id] => 11066175 [patent_doc_number] => 20160263139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS' [patent_app_type] => utility [patent_app_number] => 15/028983 [patent_app_country] => US [patent_app_date] => 2014-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9433 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028983 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/028983
ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS Oct 6, 2014 Abandoned
Array ( [id] => 14454211 [patent_doc_number] => 10323057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Amphotericin B derivatives with improved therapeutic index [patent_app_type] => utility [patent_app_number] => 15/026520 [patent_app_country] => US [patent_app_date] => 2014-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 16384 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026520 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/026520
Amphotericin B derivatives with improved therapeutic index Oct 5, 2014 Issued
Array ( [id] => 10214878 [patent_doc_number] => 20150099870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-09 [patent_title] => 'Glycosylation Reactions Using Phenyl(trifluoroethyl)iodonium Salts' [patent_app_type] => utility [patent_app_number] => 14/505808 [patent_app_country] => US [patent_app_date] => 2014-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7544 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505808 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/505808
Glycosylation reactions using phenyl(trifluoroethyl)iodonium salts Oct 2, 2014 Issued
Array ( [id] => 11210903 [patent_doc_number] => 09439920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Composition for the management of nausea and vomiting' [patent_app_type] => utility [patent_app_number] => 14/506387 [patent_app_country] => US [patent_app_date] => 2014-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18567 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506387 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/506387
Composition for the management of nausea and vomiting Oct 2, 2014 Issued
Array ( [id] => 13251165 [patent_doc_number] => 10138262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Reactive multi-functional additives for coatings compositions [patent_app_type] => utility [patent_app_number] => 14/486059 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4372 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486059 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/486059
Reactive multi-functional additives for coatings compositions Sep 14, 2014 Issued
Array ( [id] => 17904321 [patent_doc_number] => 11458154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Treatment of CYR61- and VEGF-mediated conditions [patent_app_type] => utility [patent_app_number] => 14/917098 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917098 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/917098
Treatment of CYR61- and VEGF-mediated conditions Sep 3, 2014 Issued
Array ( [id] => 12322695 [patent_doc_number] => 09943540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid [patent_app_type] => utility [patent_app_number] => 14/476521 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2243 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476521 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/476521
Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid Sep 2, 2014 Issued
Array ( [id] => 14818515 [patent_doc_number] => 10406243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Methods of treatment comprising a polyrotaxane and medicinal composition [patent_app_type] => utility [patent_app_number] => 14/913978 [patent_app_country] => US [patent_app_date] => 2014-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 41 [patent_no_of_words] => 15693 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913978 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/913978
Methods of treatment comprising a polyrotaxane and medicinal composition Aug 17, 2014 Issued
Array ( [id] => 10946938 [patent_doc_number] => 20140349959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY' [patent_app_type] => utility [patent_app_number] => 14/456779 [patent_app_country] => US [patent_app_date] => 2014-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6222 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14456779 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/456779
POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY Aug 10, 2014 Abandoned
Array ( [id] => 16261231 [patent_doc_number] => 10752650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Sophorolipid compound and composition comprising same [patent_app_type] => utility [patent_app_number] => 14/911174 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 12827 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911174 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/911174
Sophorolipid compound and composition comprising same Aug 5, 2014 Issued
Array ( [id] => 9839545 [patent_doc_number] => 20150031628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 14/452993 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6676 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452993 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/452993
METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS Aug 5, 2014 Abandoned
Array ( [id] => 9858419 [patent_doc_number] => 20150038436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'TAILORED GLYCOPOLYMERS AS ANTICOAGULANT HEPARIN MIMETICS' [patent_app_type] => utility [patent_app_number] => 14/450196 [patent_app_country] => US [patent_app_date] => 2014-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 47134 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450196 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/450196
Tailored glycopolymers as anticoagulant heparin mimetics Jul 31, 2014 Issued
Array ( [id] => 14031263 [patent_doc_number] => 10227370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity [patent_app_type] => utility [patent_app_number] => 14/450192 [patent_app_country] => US [patent_app_date] => 2014-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 38879 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450192 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/450192
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity Jul 31, 2014 Issued
Array ( [id] => 9839560 [patent_doc_number] => 20150031643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II' [patent_app_type] => utility [patent_app_number] => 14/340028 [patent_app_country] => US [patent_app_date] => 2014-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5141 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340028 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/340028
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II Jul 23, 2014 Abandoned
Array ( [id] => 9839559 [patent_doc_number] => 20150031642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I' [patent_app_type] => utility [patent_app_number] => 14/340016 [patent_app_country] => US [patent_app_date] => 2014-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7759 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340016 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/340016
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I Jul 23, 2014 Abandoned
Menu